{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:27:35Z","timestamp":1766158055140,"version":"3.40.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.drugpo.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T21:47:53Z","timestamp":1490392073000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals"],"prefix":"10.1016","volume":"47","author":[{"given":"Allison","family":"Mah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael John","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Dobrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Nosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-2928","authenticated-orcid":false,"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.drugpo.2017.02.006_bib0005","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/liv.12370","article-title":"Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents","volume":"34","author":"Alavi","year":"2014","journal-title":"Liver International"},{"issue":"5","key":"10.1016\/j.drugpo.2017.02.006_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","article-title":"Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons","volume":"351","author":"Chung","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.02.006_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10826080902864894","article-title":"Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel","volume":"45","author":"Cohen-Moreno","year":"2010","journal-title":"Substance Use Misuse"},{"issue":"2","key":"10.1016\/j.drugpo.2017.02.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2013.08.007","article-title":"Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers","volume":"133","author":"Dunn","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2017.02.006_bib0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2015.01.002","article-title":"Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse: A comprehensive narrative overview of English-language studies","volume":"26","author":"Fischer","year":"2015","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2017.02.006_bib0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/dar.12396","article-title":"Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut","author":"Grau","year":"2016","journal-title":"Drug and Alcohol Review"},{"issue":"9","key":"10.1016\/j.drugpo.2017.02.006_bib0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"5","key":"10.1016\/j.drugpo.2017.02.006_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/add.12094","article-title":"High rates of midazolam injection and associated harms in Bangkok, Thailand","volume":"108","author":"Hayashi","year":"2012","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugpo.2017.02.006_bib0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.279.6.450","article-title":"Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy","volume":"279","author":"Hogg","year":"1998","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.drugpo.2017.02.006_bib0050","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","article-title":"Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy","volume":"286","author":"Hogg","year":"2001","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/j.drugpo.2017.02.006_bib0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jvh.12129","article-title":"Uptake of hepatitis C treatment among people who inject drugs attending needle and syringe programs in Australia, 1999\u20132011","volume":"21","author":"Iversen","year":"2014","journal-title":"Journal of Viral Hepatitis"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2017.02.006_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13197","article-title":"OPTN\/SRTR 2013 Annual Data Report: liver","author":"Kim","year":"2015","journal-title":"American Journal of Transplantation"},{"issue":"10","key":"10.1016\/j.drugpo.2017.02.006_bib0065","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","article-title":"The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users","volume":"97","author":"Kwiatkowski","year":"2002","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2017.02.006_bib0070","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/1094428105284919","article-title":"The sources of four commonly reported cutoff criteria: What did they really say?","volume":"9","author":"Lance","year":"2006","journal-title":"Organizational Research Methods"},{"issue":"10","key":"10.1016\/j.drugpo.2017.02.006_bib0075","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.drugpo.2015.07.002","article-title":"Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study","volume":"26","author":"Marshall","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2017.02.006_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.19.1.20617","article-title":"Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting","volume":"19","author":"Milloy","year":"2016","journal-title":"Journal of the International AIDS Society"},{"key":"10.1016\/j.drugpo.2017.02.006_bib0085","series-title":"Rethinking drinking","first-page":"1","author":"National Institutes of Health","year":"2015"},{"issue":"4","key":"10.1016\/j.drugpo.2017.02.006_bib0090","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.addbeh.2013.01.010","article-title":"High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan","volume":"38","author":"Ng","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.drugpo.2017.02.006_bib0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2334-14-74","article-title":"Community-based HCV screening: Knowledge and attitudes in a high risk urban population","volume":"14","author":"Norton","year":"2014","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.02.006_bib0100","series-title":"Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases","first-page":"1920","article-title":"Hepatitis C","author":"Ray","year":"2015"},{"issue":"10","key":"10.1016\/j.drugpo.2017.02.006_bib0105","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","article-title":"Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): A systematic review and meta-analysis","volume":"26","author":"Smith","year":"2015","journal-title":"The International Journal on Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2017.02.006_bib0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0376-8716(00)00144-7","article-title":"Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment","volume":"61","author":"Stein","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2017.02.006_bib0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.280.6.547","article-title":"Barriers to use of free antiretroviral therapy in injection drug users","volume":"280","author":"Strathdee","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.drugpo.2017.02.006_bib0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6963-7-39","article-title":"Drug treatment program patients\u2019 hepatitis C virus (HCV) education needs and their use of available HCV education services","volume":"7","author":"Strauss","year":"2007","journal-title":"BMC Health Services Research"},{"issue":"1","key":"10.1016\/j.drugpo.2017.02.006_bib0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10620-010-1455-3","article-title":"Formal patient education improves patient knowledge of hepatitis C in vulnerable populations","volume":"56","author":"Surjadi","year":"2011","journal-title":"Digestive Diseases and Sciences"},{"issue":"1\u20133","key":"10.1016\/j.drugpo.2017.02.006_bib0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.drugalcdep.2010.11.018","article-title":"Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs","volume":"116","author":"Treloar","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.drugpo.2017.02.006_bib0135","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1465-3362.2012.00468.x","article-title":"Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs","volume":"31","author":"Treloar","year":"2012","journal-title":"Drug and Alcohol Review"},{"issue":"6","key":"10.1016\/j.drugpo.2017.02.006_bib0140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"Tyndall","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.drugpo.2017.02.006_bib0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7517-3-18","article-title":"Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study","volume":"3","author":"Wood","year":"2006","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.drugpo.2017.02.006_bib0150","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ADM.0000000000000041","article-title":"Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance","volume":"8","author":"Zeremski","year":"2014","journal-title":"Journal of Addiction Medicine"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917300543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T02:59:24Z","timestamp":1535943564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917300543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"alternative-id":["S0955395917300543"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.02.006","relation":{},"ISSN":["0955-3959"],"issn-type":[{"type":"print","value":"0955-3959"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}